IncellDx and BMS partnered to develop a molecular companion diagnostic to an undisclosed BMS compound based on IncellDx's InCellCept assay

Bristol-Myers Squibb Co.

U.S. / Large-Cap Biopharma (>=$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

IncellDx Inc.

U.S. / Medical Devices and Diagnostics

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced